Portfolio

Fapajal
Paper manufacturing
EGF II | EGF III

Invested in
2022

INVESTMENT RATIONALE

Investment in a company that is essentially an exporter,  which sustainably explores tissue paper solutions to improve people's health and well-being.

 

STRATEGY

Support the development of pioneering solutions in the paper industry, focusing on the use of more sustainable raw materials and the creation of new high-quality finished products, which will allow the Company to continue on its growth trajectory, creating value and increasingly becoming a benchmark in the European tissue paper sector.

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.